FDA Inks Nanotech Agreement With Cancer And Standards Institutes
This article was originally published in The Gray Sheet
Executive Summary
FDA collaboration in the nanotechnology field with two other federal agencies may serve to facilitate premarket reviews for nanotech-based cancer diagnostics and therapeutics
You may also be interested in...
FDA nanotechnology task force
Newly formed task force will assess the agency's readiness to handle a swelling wave of medical nanotechnology, wherein the control of matter at the nano level - one thousand- to one hundred thousand-times smaller than the thickness of a sheet of paper - enables novel applications, according to an Aug. 9 release (1"The Gray Sheet" April 24, 2006, p. 12). The task force will seek to identify gaps in policy and/or institutional knowledge and craft regulatory approaches that encourage the continued development of devices that incorporate nanomaterials. A public meeting is scheduled for Oct. 10 to explore such topics as the biological interactions unique to nanotechnology that may lead to either beneficial or adverse health effects...
NCI Unveils Nanotech Initiative, Looks To Award Molecular Imaging Grants
Molecular imaging and early detection grants will be awarded by the National Cancer Institute as part of a broader $144.3 mil. nanotechnology initiative announced Sept. 13
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.